Creating vaccines and driving value through partnerships and R&D | Novavax
Novavax is a global biotechnology company with a proven vaccine technology, focused on developing our R&D assets and establishing partnerships to help protect health.
Is the Novavax COVID Vaccine Better Than mRNA ... - Scientific American
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better …
FDA authorized for emergency use Novavax COVID-19 Vaccine (2024-2025 Formula) to more closely target currently circulating variants to provide better protection against serious consequences of ...
Novavax Update: Where to Find Our COVID-19 Vaccine
Oct 7, 2024 · Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Novavax COVID-19 vaccine - Wikipedia
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations.
Novavax 2024-2025 Formula COVID-19 Vaccine Available at …
Aug 30, 2024 · Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide; Novavax's updated vaccine is the only protein-based option available in the U.S. this fall for individuals aged 12 and older
Committed to creating vaccines to help protect health | Novavax
Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Novavax's COVID-19 Vaccine: Your Questions Answered
Sep 3, 2024 · The new Novavax vaccine targets a SARS-CoV-2 variant called JN.1, which was the dominant strain in May 2024, only to be surpassed by a collection of other Omicron virus strains, including KP.2, for which the mRNA vaccines were updated to protect against.
Novavax - Wikipedia
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.
NOVAVAX COVID-19 VACCINE, ADJUVANTED (2024–2025 FORMULA) At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, and administration for 2024–25 Novavax COVID-19 Vaccine product. Ages: 12 years of age and older Manufactured-filled syringe Storage and Handling Basics Find additional guidance on storing the vaccine ...
- Some results have been removed